EDGAR Filing Documents for 0001683168-22-003262

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001683168-22-003262

Filing Date

2022-05-06

Accepted

2022-05-06 14:47:35

Documents

Period of Report

2022-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	sunshine_i10q-033122.htm iXBRL	10-Q	393650
2	CERTIFICATION	sunshine_ex3101.htm	EX-31.1	10327
3	CERTIFICATION	sunshine_ex3102.htm	EX-31.2	10233
4	CERTIFICATION	sunshine_ex3201.htm	EX-32.1	4455
10	GRAPHIC	image_002.jpg	GRAPHIC	11780
11	GRAPHIC	image_003.jpg	GRAPHIC	12868
12	GRAPHIC	image_004.jpg	GRAPHIC	9013
	Complete submission text file	0001683168-22-003262.txt		2278399

Data Files

Seq	Description	Document	Type	Size
5	XBRL SCHEMA FILE	sbfm-20220331.xsd	EX-101.SCH	20146
6	XBRL CALCULATION FILE	sbfm-20220331_cal.xml	EX-101.CAL	36283
7	XBRL DEFINITION FILE	sbfm-20220331_def.xml	EX-101.DEF	100073
8	XBRL LABEL FILE	sbfm-20220331_lab.xml	EX-101.LAB	166234
9	XBRL PRESENTATION FILE	sbfm-20220331_pre.xml	EX-101.PRE	144736
36	EXTRACTED XBRL INSTANCE DOCUMENT	sunshine_i10q-033122_htm.xml	XML	166069

Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5

Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161

Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)